Global Buerger's Disease Market is Estimated to Witness High Growth
Author : siddhi cmi | Published On : 31 Jan 2025
Buerger's disease, also known as thromboangiitis obliterans, is a chronic inflammatory disease that causes the blood vessels in the hands and feet to narrow and become blocked. Some of the key symptoms include pain, burning sensations, or ulcers in the legs or feet. The exact cause of Buerger's disease is unknown, but it is believed to have an association with smoking, as the disease is rarely seen in non-smokers. The diagnosis of Buerger's disease can be challenging and is usually based on clinical examination, patient history, and angiography. Early diagnosis and treatment through lifestyle modifications such as quitting smoking can help prevent further progression of the disease.
The Buerger's disease market is estimated to be valued at USD 421 million in 2024 and is expected to reach USD 603 million by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Key Takeaways
Key players operating in the Buerger's disease market are Getz Pharma, Eisai, Medtronic, and Boston Scientific.
Increasing awareness about Buerger's disease through various patient advocacy groups and nonprofit organizations are creating new opportunities for Buerger's Disease Market.
Asia Pacific region represents a high growth potential for the Buerger's disease market owing to growing incidences of Buerger's disease associated with increased tobacco consumption in countries like China and India.
Market drivers
Rising awareness initiatives by healthcare organizations about the importance of early diagnosis of Buerger's disease is a major market driver. Diagnosing the disease at an early stage helps in timely intervention and prevents the progression of the disease. Various social media campaigns and training programs for primary care physicians are helping to educate people about symptoms of Buerger's disease. This is increasing the rate of early detection significantly.
Here are two 300 word paragraphs on the given topics without any conclusions:
PEST Analysis
Political: The government policies and regulations play a key role in terms of availability of treatments and drugs for Buerger's disease. Strict approval procedures impact the launch of new drugs and treatments.
Economic: The spending capability of patients plays a major role in treatment costs for Buerger's disease as it requires continuous medical management. Economic recessions can negatively impact the market growth.
Social: Increased awareness about early detection and management of peripheral arterial disease aids in early diagnosis of Buerger's disease. Aging population is also a major risk factor.
Technological: Developments in minimally invasive vascular procedures such as angioplasty help provide better treatment options compared to major amputations. Advancements in drug delivery systems can help improve treatment effectiveness.
Regions where market value is concentrated
The Buerger's disease market in terms of value is majorly concentrated in few regions globally. North America represents the largest market share currently attributed to developed healthcare infrastructure and increasing disease prevalence. Within North America, the United States captures over 80% market share owing to an aging baby boomer generation and rising peripheral artery disease incidence rates. Western Europe is the second largest regional market led by countries such as Germany, United Kingdom and France. The Asia Pacific region is also witnessing steady market growth with Japan being the major revenue generator followed by China and India. Emerging nations in Latin America and Middle East & Africa currently hold lower market shares attributed to resource constraints and lack of disease awareness but represent future high growth opportunities.
Fastest growing region
The Asia Pacific region is poised to witness the fastest value growth in the global Buerger's disease market during the forecast period from 2024 to 2031. This can be attributed to rising healthcare expenditures, increasing patient affordability, rapidly evolving healthcare infrastructure and growing medical tourism industry in the region. Countries such as China and India standout as the fastest emerging markets due to their huge patient pools and improving access to sophisticated treatments. Favorable government policies supporting healthcare reforms also aid the regional market growth. Launch of newer drug molecules and minimally invasive treatment technologies will further propel the market expansion. Rising disease prevalence associated with growing smoking rates especially among young adults also makes Asia Pacific a lucrative market for major players in the long run.
Get this Report in Japanese Language: バージャー病市場
Get this Report in Korean Language: 버거병 시장
Author Bio:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.